reported that Icaritin reduced CD8+ T cell chemotaxis by inhibiting the CXCL10/CXCR3 axis and suppressing the TGF-β/Smad2 signaling pathway in COPD (41). Here, TGFB1 is linked to chronic obstructive pulmonary disease.